About Cyteir Therapeutics, Inc. 
Cyteir Therapeutics, Inc.
Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 18 Schemes (15.12%)
Foreign Institutions
Held by 20 Foreign Institutions (6.98%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2023)
Net Profit:
-4 Million
Biotechnology
USD 109 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.03
-24.82%
0.87






